BioCentury | Feb 13, 2012
Company News
Vytacera Pharma Inc., University of Minnesota deal
...The university granted newco Vytacera exclusive, worldwide rights to develop and commercialize cyanide poisoning treatment Sulfanegen...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
